Eptifibatide Injection
Product Images NDC 70436-162

This is a description of a medication called Eptifibatide, which is available in 20mg/10mL dose for intravenous use. Each mL of this medication contains 2 mg eplifibatide and 5.25 mg citric acid in water for injection, with pH adjusted with sodium hydroxide. It should be stored refrigerated and may be transferred to 25°C (77°F) for up to 2 months. The medication should be protected from light until administration and should be discarded if not used within 2 months from transfer. It comes in 1x10 mL single-dose vial and usual dosage should be seen in the package insert provided. The medication is manufactured by Heinan Poly Pharm Co. in China and dispersed by Slate Run Pharmaceuticals LLC in the United States.*

This is a description of Eptifibatide, which is available in a 75mg/100mL vial for weight-adjusted bolus dosing via intravenous use only. The injection contains 0.75mg of Eptifibatide and 5.25mg of citric acid in water for injection with pH adjusted with sodium hydroxide to a pH of 5.35. The usual dosage is mentioned in the package insert. It is recommended to store the injection at 2° to 8°C (36° to 46°F) in a dark place until administration to prevent spoilage. The injection can be transferred to a U.S. Pharmacopeia (USP) Controlled Room Temperature (25°C or 77°F) for up to two months, but must be discarded after that period. The text also contains information about manufacturing and distribution.*

This is a description of Eptifibatide Injection, used for intravenous purposes with a bolus dosage for weight adjustment. It is manufactured by Heinan Poly Pharm. Co., Ltd in China and is available in a 10 mL single-dose vial with a 20mg/10mL concentration. Each mL contains 2mg of eptifibatide and 5.25mg of citric acid in water for pH-adjusted injection with sodium hydroxide. Usual dosage and storage conditions are mentioned and recommended. The product is distributed by State Run Pharmaceuticals, LLC of Columbus, Ohio 43215. However, there is some gibberish text in the initial part, which could not be evaluated.*

This is a description of Eptifibatide Injection used for intravenous use only. Each mL of the injection contains 0.75mg of eptifibatide and 5.25mg of citric acid in water for injection. The pH of the injection is adjusted with sodium hydroxide and maintained at 5.35. The drug must be refrigerated at 2-8°C and may be transferred to 25°C for two months. This injection is intended for weight-adjusted bolus dosing and is available in a 75 mg/100 mL single-dose vial. The accompanying package insert should be referred to for usual dosage instructions.*